| Literature DB >> 31973698 |
Pangbo Wang1, Kang Ma1, Tunan Chen1, Xingsen Xue1, Dada Ma1, Shi Wang1, Xin Chen1, Hui Meng1, Gaoyu Cui1, Boyuan Gao1, Jiangkai Lin1, Hua Feng2, Weihua Chu3.
Abstract
BACKGROUND: Progressive spinal deformity has become a well-recognized complication of intracanal tumors resection. However, the factors affecting post-operative spinal stability remain to be further research. Here, we described the current largest series of risk factors analysis for progressive spinal deformity following resection of intracanal tumors.Entities:
Keywords: Intracanal tumors; Progressive spinal deformity; Risk factors
Mesh:
Year: 2020 PMID: 31973698 PMCID: PMC6977227 DOI: 10.1186/s12883-019-1594-x
Source DB: PubMed Journal: BMC Neurol ISSN: 1471-2377 Impact factor: 2.474
Fig. 1The T2-weighted MR images shown was a 30-year-old woman who underwent resection of the ependymoma spanning from C3 to T2. a Preoperative MR images showed a huge tumor and the cervical spine had lost its normal curvature. b Postoperative MR images during postoperative hospitalization showed complete resection of spinal cord tumor and almost no change in cervical curvature. c The follow-up MR image showed progressive cervical kyphosis 6 months after the operation. d, e The follow-up MR image showed deterioration of progressive cervical kyphosis 13 months and 24 months after the operation, respectively. f The CT three-dimensional reconstruction image showed the cervical kyphosis 24 months after the operation. At that time, the patient complained that her left upper limb was numb
Baseline Patient Demographics, Comorbidities, and Operative Factors
| Variable | Value |
|---|---|
| Sex, n(%) | |
| Female | 145 (53.3%) |
| Male | 127 (46.7%) |
| Age in yrs | 42.56 ± 16.18 |
| BMI (kg/m2) | 23.28 ± 3.49 |
| Symptom duration in mos | 19.65 (0–240) |
| Presenting symptoms | |
| Back pain, n(%) | 152 (55.9%) |
| Motor weakness, n (%) | 139 (51.1%) |
| Sensory abnormal, n (%) | 108 (39.7%) |
| Sphincter disturbances, n (%) | 47 (17.3%) |
| Median preop MMS score (IQR) | 3 (2–3) |
| Location, n (%) | |
| Cervical | 50 (18.4%) |
| Cervicothoracic | 20 (7.4%) |
| Thoracic | 103 (37.9%) |
| Thoracolumbar | 29 (10.7%) |
| Lumbar | 70 (25.7%) |
| Vertebral levels of tumor involvement, n (%) | |
| 1 | 69 (25.4%) |
| 2 | 136 (50%) |
| 3 | 39 (14.3%) |
| 4 | 15 (5.5%) |
| 5 | 3 (1.1%) |
| 6 | 2 (0.7%) |
| 7 | 4 (1.5%) |
| 8 | 1 (0.4%) |
| 12 | 3 (1.1%) |
| Previous treatment, n(%) | |
| Biopsy | 4 (1.5%) |
| Chemotherapy | 1 (0.4%) |
| Preop spinal deformity, n(%) | |
| No | 275 (97.4%) |
| Yes | 7 (2.6%) |
| Postop spinal deformity, n(%) | |
| No | 229 (84.2) |
| Yes | 43 (15.8) |
Surgical and tumor characteristics
| Sugery methods (laminectomy or laminoplasty) | |
|---|---|
| laminoplasty | 253 (93%) |
| laminectomy | 19 (7%) |
| Extent of Surgery resection (no. of spinal levels) | |
| 1 | 53 (19.5%) |
| 2 | 151 (55.5%) |
| 3 | 44 (16.2%) |
| 4 | 16 (5.9%) |
| 5 | 3 (1.1%) |
| 7 | 3 (1.1%) |
| 8 | 1 (0.4%) |
| 10 | 1 (0.4%) |
| Extent of tumor resection | |
| GTR | 255 (93.8%) |
| STR | 15 (5.5%) |
| Partial resection | 2 (0.7%) |
| Intramedullary or Extramedullary, n(%) | |
| Intramedullary | 45 (16.5%) |
| Extramedullary | 237 (83.5%) |
| Surgeon, n (%) | |
| Dr. Lin | 98 (36%) |
| Dr. Meng | 50 (18.4%) |
| Dr. Cui | 38 (14%) |
| Dr. Gao | 36 (13.2%) |
| Dr. Wu | 25 (9.2%) |
| Other | 25 (9.2%) |
| Pathology, n (%) | |
| Neurinoma | 123 (45.2%) |
| Meningioma | 41 (15.1%) |
| Ependymoma | 23 (8.5%) |
| Cyst | 15 (5.5%) |
| Angioma | 19 (7%) |
| Other | 51 (18.8%) |
Postoperative outcomes and complications
| Surgical site infection, n (%) | 7 (2.6%) |
|---|---|
| Incisional CSF leak, n (%) | 9 (3.3%) |
| Neurologic complications during hospitalization, n (%) | 19 (7%) |
| Postoperative length of hospital stay, n | 16.79 ± 8.34 |
| Median MMS score at last FU (IQR) | 1 (1–1) |
| Mean FU in mos (range) | 21.82 (6–114) |
| Time of spinal deformity in mos (range) | 13.23 (2–60) |
| Postoperative brace fixation, n(%) | 256 (94.1%) |
Fig. 2Age distribution of progressive spinal deformity in patients who underwent resection of intracanal tumors
Clinical features of patients who developed progressive spinal deformity following SCTs resection
| Case (#) | Sex | Age range (yrs) | Spinal segment (C/T/L/S) | TumorlocatIon (I/E) | Preop Spinal Deformity (yes/no) | Types of preoperative spinal deformity (yes/no) | Sugery methods | Number of levels | Surgeon | Types of postoperative spinal deformity | Time of spinal deformity in mos | Symptoms of occuranceof radiological deformity (yes/no) | Pathology | Grade | Extent of tumor resection | ClinicalStatus | Postoperative brace fixation (yes/no) | Postoperative spinal fusion (yes/no) | Pre-op MMS | MMS at FU | CSF leak | FU (mos) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | M | 31–35 | L | E | no | no | Laminoplasty | 3 | Dr. Lin | kyphosis | 10 | no | Cyst | low | GTR | Improved | yes | no | 4 | 2 | No | 10 | |
| 2 | M | 81–85 | L | I | no | no | Laminoplasty | 1 | Dr. Lin | lordosis | 32 | no | Neurinoma | low | GTR | Improved | yes | no | 3 | 1 | No | 32 | |
| 3 | F | 51–55 | C | I | no | no | Laminoplasty | 4 | Dr. Gao | kyphosis | 3 | no | Neurinoma | low | GTR | Improved | yes | no | 3 | 1 | No | 7 | |
| 4 | M | 51–55 | T | I | no | no | Laminoplasty | 2 | Dr. Cui | kyphosis | 32 | no | Meningioma | low | GTR | Improved | yes | no | 2 | 1 | No | 32 | |
| 5 | M | 46–50 | L | I | no | no | Laminoplasty | 1 | Dr. Wu | lordosis | 3 | no | Neurinoma | low | GTR | Improved | yes | no | 2 | 1 | No | 7 | |
| 6 | M | 11–15 | T | I | yes | Scoliosis | Laminoplasty | 2 | Dr. Lin | Scoliosis; kyphosis | 29 | yes | Neurinoma | low | GTR | Improved | no | no | 2 | 1 | No | 52 | |
| 7 | F | 6–10 | CT | I | no | no | Laminoplasty | 7 | Dr. Lin | kyphosis | 4 | no | Ependymoma | High | GTR | Improved | yes | no | 3 | 1 | No | 6 | |
| 8 | M | 11–15 | T | I | yes | Scoliosis | Laminoplasty | 2 | Dr. Lin | Scoliosis; kyphosis | 6 | no | Neurinoma | low | GTR | Improved | no | no | 2 | 1 | no | 48 | |
| 9 | M | 6–10 | T | I | no | no | Laminoplasty | 3 | Dr. Wu | kyphosis | 3 | no | Neurinoma | low | GTR | Improved | yes | no | 4 | 2 | no | 3 | |
| 10 | M | 16–20 | C | I | yes | Scoliosis | Laminoplasty | 2 | Dr. Lin | Scoliosis; lordosis | 6 | no | Neurinoma | low | GTR | Improved | yes | no | 2 | 1 | no | 7 | |
| 11 | F | 1–5 | L | I | no | no | Laminoplasty | 2 | Dr. Cui | lordosis | 5 | no | Other | high | GTR | Improved | yes | no | 3 | 1 | no | 6 | |
| 12 | F | 11–15 | T | I | no | no | Laminoplasty | 2 | Dr. Lin | kyphosis | 3 | yes | Other | low | GTR | improved | yes | no | 3 | 2 | no | 11 | |
| 13 | M | 11–15 | CT | I | no | no | Laminoplasty | 3 | Dr. Lin | kyphosis | 4 | no | glioma | high | Partial resection | Improved | yes | no | 3 | 1 | no | 21 | |
| 14 | F | 41–45 | T | I | no | no | Laminoplasty | 2 | Dr. Lin | kyphosis | 14 | no | Ependymoma | high | GTR | improved | yes | no | 3 | 1 | no | 14 | |
| 15 | F | 26–30 | CT | I | no | no | Laminoplasty | 10 | Dr. Lin | kyphosis | 2 | no | Ependymoma | high | GTR | improved | yes | no | 3 | 1 | no | 25 | |
| 16 | M | 16–20 | C | E | no | no | Laminoplasty | 2 | Other | kyphosis | 27 | no | Neurinoma | low | GTR | improved | yes | no | 3 | 1 | no | 39 | |
| 17 | M | 26–30 | T | I | yes | Scoliosis | Laminoplasty | 3 | Dr. Lin | Scoliosis; kyphosis | 6 | no | Other | high | GTR | Improved | yes | no | 3 | 1 | no | 6 | |
| 18 | F | 41–45 | L | I | no | no | Laminoplasty | 2 | Dr. Cui | lordosis | 15 | no | Neurinoma | low | GTR | Improved | yes | no | 3 | 1 | no | 27 | |
| 19 | F | 21–25 | C | E | no | no | Laminoplasty | 3 | Dr. Wu | kyphosis | 39 | no | Cyst | low | GTR | Improved | yes | no | 2 | 1 | no | 39 | |
| 20 | M | 11–15 | L | I | no | no | Laminoplasty | 7 | Dr. Lin | lordosis | 2 | no | Immature teratoma | high | GTR | Improved | no | no | 5 | 4 | no | 3 | |
| 21 | F | 41–45 | T | I | no | no | Laminoplasty | 3 | Dr. Meng | kyphosis | 26 | yes | Meningioma | low | GTR | Worsen | yes | no | 3 | 4 | no | 28 | |
| 22 | M | 6–10 | TL | I | yes | kyphosis | Laminoplasty | 2 | Dr. Lin | kyphosis | 3 | yes | Cyst | low | GTR | Improved | yes | yes | 2 | 1 | no | 24 | |
| 23 | F | 46–50 | L | I | no | no | Laminoplasty | 1 | Dr. Lin | lordosis | 14 | no | Neurinoma | low | GTR | Improved | yes | no | 3 | 1 | no | 14 | |
| 24 | F | 11–15 | TL | I | no | Scoliosis | Laminoplasty | 2 | Dr. Lin | Scoliosis; lordosis | 60 | no | Cyst | low | GTR | Improved | yes | yes | 2 | 1 | no | 60 | |
| 25 | F | 61–65 | C | I | no | no | Laminoplasty | 3 | Other | kyphosis | 2 | no | Meningioma | low | GTR | Improved | yes | no | 3 | 1 | No | 2 | |
| 26 | M | 41–15 | L | I | no | no | Laminoplasty | 2 | Other | lordosis | 6 | no | Cyst | low | GTR | Improved | yes | no | 3 | 1 | no | 6 | |
| 27 | F | 41–45 | TL | I | no | no | Laminoplasty | 3 | Dr. Cui | kyphosis | 3 | no | Cyst | low | GTR | Improved | yes | no | 3 | 1 | no | 3 | |
| 28 | M | 11–15 | CT | I | no | no | Laminoplasty | 2 | Dr. Meng | kyphosis | 11 | no | Neurinoma | low | GTR | Improved | yes | no | 3 | 1 | no | 39 | |
| 29 | M | 6–10 | TL | I | no | no | Laminoplasty | 2 | Dr. Cui | kyphosis | 6 | no | Ependymoma | High | STR | Improved | yes | no | 4 | 1 | no | 54 | |
| 30 | M | 31–35 | T | I | no | no | Laminoplasty | 4 | Dr. Lin | kyphosis | 60 | no | glioma | high | GTR | Improved | yes | no | 3 | 1 | no | 60 | |
| 31 | M | 16–20 | LS | I | no | no | Laminoplasty | 1 | Dr. Wu | lordosis | 3 | no | Neurinoma | low | GTR | Improved | yes | no | 2 | 1 | no | 3 | |
| 32 | F | 11–15 | T | I | yes | Scoliosis | Laminoplasty | 8 | Dr. Lin | Scoliosis; kyphosis | 60 | no | Other | low | GTR | Improved | yes | no | 3 | 1 | no | 60 | |
| 33 | F | 41–45 | L | I | no | no | Laminoplasty | 2 | Dr. Cui | lordosis | 3 | no | Neurinoma | low | GTR | Improved | yes | no | 2 | 1 | No | 18 | |
| 34 | M | 41–45 | CT | I | no | no | Laminoplasty | 2 | Dr. Lin | kyphosis | 3 | no | Ependymoma | high | GTR | Improved | yes | no | 2 | 1 | no | 19 | |
| 35 | F | 41–45 | T | I | no | no | Laminoplasty | 2 | Dr. Cui | kyphosis | 3 | no | Neurinoma | low | GTR | Improved | yes | no | 2 | 1 | no | 36 | |
| 36 | M | 11–15 | TL | I | no | no | Laminoplasty | 2 | Dr. Cui | kyphosis | 10 | no | Neurinoma | low | GTR | Improved | yes | no | 2 | 1 | no | 10 | |
| 37 | F | 31–35 | T | I | no | no | Laminoplasty | 1 | Dr. Lin | kyphosis | 3 | no | Angioma | low | GTR | Improved | yes | no | 3 | 1 | No | 14 | |
| 38 | M | 46–50 | C | I | no | no | laminectomy | 2 | Dr. Cui | kyphosis | 3 | no | Other | low | GTR | Improved | yes | no | 3 | 1 | no | 6 | |
| 39 | M | 46–50 | C | I | no | no | laminectomy | 2 | Dr. Meng | kyphosis | 6 | no | Neurinoma | low | GTR | Improved | yes | no | 3 | 1 | no | 4 | |
| 40 | F | 41–45 | T | I | no | no | laminectomy | 2 | Dr. Lin | kyphosis | 5 | no | Meningioma | low | GTR | Improved | yes | no | 2 | 1 | no | 5 | |
| 41 | M | 46–50 | T | I | no | no | laminectomy | 2 | Dr. Wu | kyphosis | 29 | no | Neurinoma | low | GTR | Improved | yes | no | 3 | 2 | no | 29 | |
| 42 | M | 11–15 | CT | I | no | no | laminectomy | 3 | Dr. Gao | lordosis | 2 | no | Immature teratoma | High | GTR | Improved | yes | no | 5 | 3 | yes | 1 | |
| 43 | F | 41–45 | C | I | no | no | Laminoplasty | 2 | Other | lordosis | 3 | no | Meningioma | High | GTR | Improved | yes | no | 3 | 1 | yes | 6 |
Univariate analysis for predicting risk factors of progressive spinal deformity
| Variable | |
|---|---|
| Sex | |
| Age | |
| BMI | |
| Symptom duration in mos | |
| Presenting symptoms | |
| Back pain | 0.497 |
| Motor weakness | 0.181 |
| Sensory abnormal | 0.166 |
| Sphincter disturbances | 0.850 |
| Median preop MMS score | |
| Location of tumor | |
| Vertebral levels of tumor involvement | |
| Previous treatment | |
| Biopsy | |
| Chemotherapy | 1.000 |
| Preop spinal deformity | |
| Extent of Surgery resection involvement | |
| Extent of tumor resection | 0.750 |
| Intramedullary or Extramedullary | |
| Surgeon | |
| Pathology | |
| Median MMS score at last FU | |
Data set in bold are statistically significant
Multivariate logistic regression analysis for predicting risk factors of progressive spinal deformity in patients who underwent laminoplasty or laminectomy
| Variable | OR | 95% CI | |
|---|---|---|---|
| Sex | 0.812 | 0.325–2.033 | 0.657 |
| Age ≤ 18 years | 3.941 | 1.165–13.327 | |
| BMI | 1.105 | 0.971–1.256 | 0.129 |
| Symptom duration in mos | 1.006 | 0.99–1.022 | 0.497 |
| Median preop MMS score | 0.700 | 0.385–1.275 | 0.244 |
| Location of tumor | 0.413 | ||
| Cervical | 2.628 | 0.712–9.706 | 0.147 |
| Cervicothoracic | 0.743 | 0.164–3.358 | 0.699 |
| Thoracic | 1.650 | 0.526–5.175 | 0.39 |
| Thoracolumbar | 2.436 | 0.527–11.263 | 0.255 |
| Vertebral levels of tumor involvement | 0.697 | 0.516–0.942 | |
| Previous treatment | 2.703 | 0.121–60.35 | 0.53 |
| Preop spinal deformity | 27.112 | 2.408–305.316 | |
| Extent of Surgery resection involvement | 1.061 | 0.691–1.63 | 0.785 |
| Surgeon | 0.226 | ||
| Dr. Lin | 0.739 | 0.168–3.247 | 0.688 |
| Dr. Meng | 2.490 | 0.393–15.763 | 0.332 |
| Dr. Cui | 0.472 | 0.102–2.19 | 0.338 |
| Dr. Gao | 2.844 | 0.404–20.005 | 0.294 |
| Dr. Wu | 0.802 | 0.144–4.46 | 0.801 |
| Pathology | 0.634 | ||
| Neurinoma | 0.443 | 0.14–1.407 | 0.167 |
| Meningioma | 0.375 | 0.087–1.612 | 0.187 |
| Ependymoma | 0.478 | 0.104–2.2 | 0.343 |
| Cyst | 0.378 | 0.074–1.948 | 0.245 |
| Angioma | 1.156 | 0.121–11.085 | 0.9 |
| Median MMS score at last FU | 0.852 | 0.403–1.802 | 0.674 |
| Intramedullary or Extramedullary | 0.497 | 0.188–1.312 | 0.158 |
Data set in bold are statistically significant